cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5c5x | A | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5c5x | B | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5c5x | C | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5c5x | D | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5c5x | E | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5c5x | F | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5c5x | G | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5c5x | H | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5dye | B | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5dye | C | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 5dye | D | L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 3d9s | B | L47 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 3d9s | A | L47 L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 3d9s | C | L47 L163 | PS6 | | O-[(S)-{[(2S)-2-(HEXANOYLOXY)-3-(TETRADECANOYLOXY)PROPYL]OXY}(HYDROXY)PHOSPHORYL]-D-SERINE | 3d9s | D | L47 L163 |
LBS | AA sequence | # species | Species |
G159 | RTSPVGSPALS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L163 | VGSPALSIGLS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L167 | ALSIGLSVTLG | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L47 | ILQISIAFGLA | 2 | Mus musculus, Rattus norvegicus | L47 | ILQIALAFGLA | 1 | Homo sapiens | P157 | SRRTSPVGSPA | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | S156 | DSRRTSPVGSP | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | S160 | TSPVGSPALSI | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | V158 | RRTSPVGSPAL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus |